Dow Up0.17% Nasdaq Up0.29%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
4.15 Aug 26, 3:58PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 30, 2014Apr 30, 2013Apr 30, 2012
Total Revenue 289   1,234   415  
Cost of Revenue130  43  51  
Gross Profit 159   1,191   364  
Operating Expenses
Research Development2,997  2,456  2,463  
Selling General and Administrative13,773  3,676  6,092  
Non Recurring -  248  30  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (16,611) (5,189) (8,220)
Income from Continuing Operations
Total Other Income/Expenses Net(718)12  (80)
Earnings Before Interest And Taxes(17,330)(5,177)(8,300)
Interest Expense2,212  4,238  7,412  
Income Before Tax(19,542)(9,416)(15,712)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(19,542)(9,416)(15,712)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (19,542) (9,416) (15,712)
Preferred Stock And Other Adjustments(5,803)(958) -  
Net Income Applicable To Common Shares (25,345) (10,374) (15,712)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.